查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1715635

动物用药品市场（按产品、动物类型、给药方式、适应症、分销管道和最终用户划分）—2025 年至 2030 年全球预测

Veterinary Pharmaceuticals Market by Products, Animal Type, Mode of Administration, Indications, Distribution Channel, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计 2023 年动物用药品市场价值将达到 374.6 亿美元，到 2024 年将以 8.35% 的复合年增长率增长至 405.3 亿美元，到 2030 年将达到 657.1 亿美元。

主要市场统计数据
基准年2023年 374.6亿美元
预计年份：2024年 405.3亿美元
预测年份 2030 657.1亿美元
复合年增长率（%） 8.35%

动物用药品市场处于创新与传统实践的交汇处，结合了数十年的成熟研究和突破性的科学进步。在快速变化的生态系统中，动物健康和福祉至关重要，新技术、不断发展的法规环境和不断变化的消费者需求正在再形成这个产业。本入门书说明了当前的市场趋势，并深入探讨了变革性转变、细分细微差别、区域划分和主要企业。

过去几年，全面的研究强调了动物用药品在确保农场动物和牲畜健康方面的重要作用。随着从农民到宠物爱好者等相关人员对功效和安全性的要求越来越高，市场也做出了回应，投资创新治疗方法来满足动物健康领域未满足的需求。了解市场动态可以帮助决策者应对这一复杂的情况。

该分析提供了以硬数据和有价值的趋势指标为依据的深入见解，指出未来既充满挑战又充满机会。对于寻求保持竞争力并满足动态产业格局需求的组织来说，这些考量至关重要。本书以分析的观点编写，弥合了科学研究与商务策略之间的差距，提供专家意见和可行的策略，确保读者了解市场。

改变动物用药品格局的变革性转变

近年来，动物保健产业发生了翻天覆地的变化，并不断重新定义动物用药品产业。这种转变的核心是技术进步、监管变化和不断变化的客户期望的相互作用。数位技术融入药物开发流程、智慧诊断工具和数据主导的治疗方法正在推动整个价值链的变革。

变革的最大驱动力之一是精准医疗和生物技术工具的采用。基因图谱和诊断测试的创新使得动物健康干预措施更具针对性，使兽医能够制定更精确地满足个别动物需求的治疗方法。采用自动化和人工智慧来简化研究和临床流程进一步促进了这种转变。最终形成的生态系统的决策不仅仅基于历史数据，而且还透过即时输入和数位工具不断增强。

监管机构在塑造产业动态也发挥关键作用。更新的指导方针和不断发展的标准促使公司遵守更严格的品管，从而为市场提供更安全、更有效的产品。这些监管变革伴随着学术界和私部门之间伙伴关係机会的增加，从而创造了协作创新的环境。

这种转变不仅是技术上的，也是文化上的。人们越来越认识到动物治疗方案中可持续实践和道德考虑的重要性。随着市场参与企业努力提高透明度和课责，自然会倾向于关注动物福利和产品表现的研究。这种双重关注正在设定新的基准并重新定义在竞争日益激烈的市场中成功的意义。

在这段快速变化的时期，该产业还必须适应外部压力，包括经济波动、全球健康危机和消费者消费习惯的改变。虽然这些因素带来了挑战，但它们也是内部变革的催化剂。市场相关人员正在重新评估和思考经营模式、业务效率和创新策略，以在重新定义的市场环境中保持领先地位。

影响市场策略的关键细分洞察

详细了解市场细分可以更好地了解动物用药品运作的各种途径。基于产品的细分将市场分为药品、药用饲料和疫苗，每个类别内进一步细分。药品依止痛药、抗感染剂、抗发炎药、抗寄生虫药等次类别分析。其中，感染疾病又抗真菌药物，抗发炎药又分为非类固醇类和类固醇类。杀寄生虫剂不断发展，重点关注外部和内部杀寄生虫剂，提供一系列寄生虫威胁的专门治疗方法。

药物饲料部分本身是多方面的。透过考虑抗生素药物饲料、抗寄生虫药物饲料、生长促进剂、营养药物饲料和益生菌和益生元组合配方等产品，分析凸显了现代动物营养的多面性。对两种疫苗进行了评估，一种是灭活疫苗，一种是活疫苗，反映了有效对抗特定动物疾病的免疫策略的进步。

按动物类型细分，将市场分为伴同性动物和农场动物，可以提供进一步的见解。伴同性动物细分为以猫、狗和马为重点的研究，每种动物都有其自身的健康挑战和市场需求。另一方面，牲畜包括牛、家禽、绵羊/山羊和猪，每种动物的饲养方法和风险状况都不同。

此外，另一个重要类别—给药方法，显示出治疗通讯协定的显着变化。在这一领域，注射剂型分为肌肉注射和皮下注射，口服剂型包括胶囊、液体悬浮液、糖浆和锭剂，局部治疗已在乳膏、洗剂和软膏中显示出其价值。这些研究强调了使用者偏好、成本效益和治疗实施的细微差别。

按适应症细分可深入研究特定的动物健康需求，包括慢性和急性疼痛管理、免疫系统疾病、感染疾病、整形外科失调、神经系统疾病、骨科感染疾病、寄生虫感染和生殖健康问题。此类别对于匹配治疗发展和临床需求至关重要。

其他细分包括分销管道，其中关注线上药局、零售药局和兽医诊所的角色。同样，最终用户类别的分析区分了动物农场、宠物饲主和兽医诊所。这些全面的见解为决策者提供了多维的市场视角，使他们能够制定策略来满足不同相关人员的特定需求和期望。

综合的细分方法不仅可以明确市场组成，还可以识别新兴趋势和利基机会。它有助于比较分析和策略优先排序，将每个部分视为更广泛的市场生态系统中的关键要素。对每个细分市场的深入了解为推动市场渗透和永续成长的客製化策略铺平了道路。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 牲畜和宠物疾病发生率不断上升，治疗和药物需求不断增加
      • 兽医医学研发活动增加
    • 限制因素
      • 召回与动物医药和疫苗相关的风险
    • 机会
      • 新型先进动物用药品的开发
      • 企业加大投资，扩大兽医疫苗接种设施
    • 任务
      • 对兽用疫苗副作用的担忧
  • 市场区隔分析
    • 产品：对医疗饲料的需求不断增加，以改善动物健康和生产力
    • 动物类型：疾病控制和生产力提高推动了牲畜对动物用药品的需求
    • 给药方法：增加胶囊的使用，以确保剂量的准确性
    • 适应症：重点在于引进药物以推进代谢紊乱的治疗
    • 分销管道：便利性和更广泛的产品范围正在推动消费者对网路药局的偏好
    • 最终使用者：宠物饲主扩大动物用药品使用
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章动物用药品产品市场

  • 介绍
  • 药物
    • 止痛药
    • 抗感染药物
      • 抗生素
      • 抗真菌药物
    • 抗发炎药物
      • 非类固醇类
      • 类固醇
    • 杀寄生虫剂
      • 杀外寄生虫剂
      • 体内杀寄生虫剂
  • 药用饲料
    • 含抗生素的饲料
    • 驱虫饲料
    • 生长促进剂
    • 营养和药用饲料
    • 益生菌和益生元配方药饲料
  • 疫苗
    • 灭活疫苗
    • 活病毒疫苗

第七章动物用药品动物类型）

  • 介绍
  • 伴同性动物
    • 猫
    • 狗
    • 马
  • 家畜
    • 牛
    • 家禽
    • 绵羊和山羊
    • 猪

第八章动物用药品市场按管理方式

  • 介绍
  • 注射
    • 肌肉注射
    • 皮下
  • 口服
    • 胶囊
    • 液体悬浮液和糖浆
    • 锭剂
  • 话题
    • 奶油
    • 洗剂
    • 软膏

第九章动物用药品适应症）

  • 介绍
  • 慢性和急性疼痛管理
  • 免疫状态
  • 感染疾病
  • 代谢紊乱
  • 神经系统疾病
  • 整形外科疾病
  • 寄生虫感染疾病
  • 生殖健康

第 10 章动物用药品市场（按分销管道）

  • 介绍
  • 网路药局
  • 零售药局
  • 兽医诊所

第 11 章动物用药品市场（按最终用户）

  • 介绍
  • 动物农庄
  • 宠物饲主
  • 兽医诊所

第 12 章：美洲动物用药品市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

13. 亚太动物用药品市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十四章欧洲、中东和非洲动物用药品市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十五章竞争格局

  • 2023年市场占有率分析
  • 2023年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • Aurora Pharmaceutical, Inc.
  • Biogenesis Bago SA
  • Biovac Ltd.
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Chanelle Pharma
  • China Animal Husbandry Industry Co., Ltd.
  • Dechra Pharmaceuticals PLC
  • ECO Animal Health Group PLC
  • Elanco Animal Health Incorporated
  • Heska Corporation
  • Hester Biosciences Limited
  • Indian Immunologicals Ltd.
  • Intas Pharmaceuticals Ltd.
  • Laboratorio Drag Pharma Chile Invetec SA
  • Merck & Co., Inc.
  • Neogen Corporation
  • Norbrook Group
  • Phibro Animal Health Corporation
  • Teknofarma Srl
  • Vetoquinol Group
  • Vetpharma Animal Health SL by Insud Pharma SLU
  • Virbac SA
  • Zendal Group
  • Zoetis Inc.
Product Code: MRR-032F197B035E

The Veterinary Pharmaceuticals Market was valued at USD 37.46 billion in 2023 and is projected to grow to USD 40.53 billion in 2024, with a CAGR of 8.35%, reaching USD 65.71 billion by 2030.

KEY MARKET STATISTICS
Base Year [2023] USD 37.46 billion
Estimated Year [2024] USD 40.53 billion
Forecast Year [2030] USD 65.71 billion
CAGR (%) 8.35%

The veterinary pharmaceuticals market stands at the crossroads of innovation and traditional practices, blending decades of established research with breakthrough scientific advancements. In a rapidly changing ecosystem where the health and welfare of animals are paramount, the industry is being reshaped by new technologies, evolving regulatory environments, and shifting consumer demands. This introductory segment provides a panoramic view of current market trends, setting the stage for a detailed exploration of transformative shifts, segmentation nuances, regional distinctions, and leading companies.

Over the past few years, comprehensive research has highlighted the pivotal role that veterinary pharmaceuticals play in ensuring the wellbeing of domesticated and livestock animals alike. As stakeholders from farm owners to pet enthusiasts demand greater efficacy and safety, the market has responded by investing in innovative treatments and addressing unmet needs in animal health. By understanding the market dynamics at play, decision-makers are better positioned to navigate this complex landscape.

This analysis provides in-depth insights supported by solid data and valuable trend indicators, illustrating a future that is both challenging and ripe with opportunities. Such insights are crucial for organizations looking to remain competitive and responsive to the demands of a dynamic industry landscape. Prepared with an analytical lens, the content that follows bridges the gap between scientific research and business strategy, ensuring that expert opinions and actionable strategies guide the reader's understanding of the market.

Transformative Shifts Revolutionizing the Veterinary Pharmaceuticals Landscape

Recent years have witnessed transformative shifts that continue to redefine the veterinary pharmaceuticals industry. At the core of these shifts is an interplay between technological advancements, regulatory transformations, and evolving customer expectations. The integration of digital technologies into drug development processes, smart diagnostics tools, and data-driven treatment methodologies has catalyzed change across the value chain.

One of the most significant drivers of transformation lies in the incorporation of precision medicine and biotechnological tools. Innovations in genetic mapping and diagnostic testing have enabled more targeted interventions in animal health, allowing veterinarians to prescribe treatments that cater more precisely to individual animals' needs. This shift is being further bolstered by the adoption of automation and artificial intelligence, streamlining processes in both research and clinical practice. The result is an ecosystem where decision-making is not solely dependent on historical data but is continuously enhanced by real-time inputs and digital tools.

Regulatory bodies have also played a critical role in shaping industry dynamics. Updated guidelines and evolving standards have pushed companies to adhere to stricter quality controls, thereby ensuring safer and more effective products on the market. This regulatory evolution is complemented by increased partnership opportunities between academia and the private sector, fostering an environment of collaborative innovation.

The transformation is not only technological but also cultural. There is a growing recognition of the importance of sustainable practices and ethical considerations in animal treatment protocols. As market participants strive for improved transparency and accountability, there is a natural alignment towards research that emphasizes both animal welfare and product performance. This dual focus is setting new benchmarks and redefining what success looks like in an increasingly competitive market.

Throughout this period of rapid change, the industry has also had to adapt to external pressures, including economic fluctuations, global health crises, and altered consumer spending habits. Although these factors present challenges, they also serve as catalysts for interior change. Market players have responded by revisiting and revamping business models, operational efficiencies, and innovation strategies to stay ahead of the curve in a redefined market landscape.

Key Segmentation Insights Shaping Market Strategy

A close examination of market segmentation provides a deeper understanding of the diverse avenues through which veterinary pharmaceuticals operate. The product-based segmentation divides the market into drugs, medicinal feed, and vaccines, with each category offering further granularity. Drugs are analyzed based on subcategories such as analgesics, anti-infectives, anti-inflammatories, and parasiticides. Within these, anti-infectives are further broken down to highlight antibiotics and antifungals, while anti-inflammatories are classified as non-steroidal or steroidal in nature. Parasiticides continue to evolve with a focus on both ectoparasiticides and endoparasiticides, offering specialized treatments that target various parasitic threats.

The medicinal feed segment itself incorporates multiple dimensions. By reviewing products such as antibiotic medicated feed, antiparasitic medicated feed, growth promoters, nutritional medicated feed, and formulations that combine probiotics and prebiotics, the analysis underscores the multifaceted nature of modern animal nutrition. Vaccines rounded out by their own line of inquiry, are assessed in terms of inactivated and live formulations, reflecting advancements in immunization strategies that are efficiently tailored to specific animal illnesses.

Animal type segmentation brings another layer of insight, categorizing the market into segments that revolve around companion animals and livestock animals. The companion animal segment is further divided through studies focusing on cats, dogs, and horses, each of which presents unique health challenges and market requirements. Meanwhile, the livestock category covers cattle, poultry, sheep and goats, and swine, each managed under distinct husbandry practices and risk profiles.

Furthermore, the mode of administration, another critical segmentation, reveals significant shifts in treatment protocols. In this segment, injectable formulations are dissected into intramuscular and subcutaneous applications; oral formulations encompass capsules, liquid suspensions and syrups, as well as tablets; while topical treatments demonstrate their value through creams, lotions, and ointments. These investigations highlight user preferences, cost-effectiveness, and the nuances in therapeutic delivery.

The segmentation based on indications delves into the specific health needs of animals, addressing areas including chronic and acute pain management, immunological conditions, infectious diseases, metabolic disorders, neurological conditions, orthopedic issues, parasitic infections, and reproductive health concerns. This category is pivotal in aligning therapeutic developments with clinical necessities.

Additional segmentation dimensions include the distribution channel, which is reviewed by examining the roles of online pharmacies, retail pharmacies, and veterinary clinics. Similarly, an analysis of the end user category distinguishes among animal farms, pet owners, and veterinary hospitals. These comprehensive insights provide decision-makers with a multidimensional view of the market, ensuring that strategies are finely attuned to the specific needs and expectations of diverse stakeholders.

The integrated approach to segmentation not only clarifies market composition but also enables the identification of emerging trends and niche opportunities. It facilitates comparative analysis and strategic prioritization, ensuring that each segment is treated as a critical element in the broader market ecosystem. The granular understanding of each segment paves the way for tailored strategies that can drive both market penetration and sustained growth.

Based on Products, market is studied across Drugs, Medicinal Feed, and Vaccines. The Drugs is further studied across Analgesics, Anti-Infectives, Anti-Inflammatories, and Parasiticides. The Anti-Infectives is further studied across Antibiotics and Antifungals. The Anti-Inflammatories is further studied across Non-Steroidal and Steroidal. The Parasiticides is further studied across Ectoparasiticides and Endoparasiticides. The Medicinal Feed is further studied across Antibiotic Medicated Feed, Antiparasitic Medicated Feed, Growth Promoters, Nutritional Medicated Feed, and Probiotic & Prebiotic Medicated Feed. The Vaccines is further studied across Inactivated Vaccines and Live Vaccines.

Based on Animal Type, market is studied across Companion Animals and Livestock Animals. The Companion Animals is further studied across Cats, Dogs, and Horses. The Livestock Animals is further studied across Cattle, Poultry, Sheep & Goats, and Swine.

Based on Mode of Administration, market is studied across Injectable, Oral, and Topical. The Injectable is further studied across Intramuscular and Subcutaneous. The Oral is further studied across Capsules, Liquid Suspension & Syrup, and Tablets. The Topical is further studied across Creams, Lotions, and Ointments.

Based on Indications, market is studied across Chronic & Acute Pain Management, Immunological Conditions, Infectious Diseases, Metabolic Disorders, Neurological Disorders, Orthopedic Disorders, Parasitic Infections, and Reproductive Health.

Based on Distribution Channel, market is studied across Online Pharmacies, Retail Pharmacies, and Veterinary Clinics.

Based on End User, market is studied across Animal Farms, Pet Owners, and Veterinary Hospitals.

Regional Insights Across Global Markets

A detailed examination of regional insights reveals synonymous trends across a spectrum of geographies that include the Americas, Europe, Middle East & Africa, and the Asia-Pacific region. The Americas emerge as a key market driven by comprehensive healthcare regulations and high levels of research and development activity, setting an example in integrated veterinary health solutions. This region showcases advanced adoption of technological innovations and a robust network of industry stakeholders.

In addition, the combined region of Europe, Middle East & Africa offers a dynamic market environment where regulatory rigor coexists with growing emphasis on animal welfare. The diversity of this region is marked by innovations in product formulations as well as adaptive strategies to meet varied regional requirements. This area benefits from both the scientific advancements emanating from Europe and the emerging opportunities in developing economies within the Middle East and Africa, thereby creating a rich tapestry of challenges and opportunities for businesses operating within this sphere.

The Asia-Pacific region presents a unique market scenario characterized by growth potential, driven by rising disposable incomes and heightened awareness regarding animal health. Investments in research and a surge in demand for advanced pharmaceuticals have stimulated market activity in this region. Here, a strong emphasis on local manufacturing and cost-effective treatment protocols has resulted in competitive product offerings that continue to drive market expansion.

Each region encapsulates distinct regulatory, economic, and cultural influences, underlining the need for a tailored approach to market strategy. Strategic investments and region-specific partnerships further enhance the potential to achieve market penetration, underscoring the importance of regional perspectives in a globally interconnected industry landscape.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, Massachusetts, New Jersey, New York, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Insights on Key Industry Players Driving the Market

The competitive landscape within the veterinary pharmaceuticals market is both diverse and dynamic, with several leading companies establishing a significant market presence. Industry giants such as Aurora Pharmaceutical, Inc. and Biogenesis Bago S.A. have been at the forefront of innovation, while Biovac Ltd. and Boehringer Ingelheim International GmbH continue to leverage their expansive resources to influence market trends. Ceva Sante Animale and Chanelle Pharma add to the competitive mix, pushing boundaries through strategic innovations and product line expansions.

China Animal Husbandry Industry Co., Ltd. and Dechra Pharmaceuticals PLC have also carved out a niche by closely aligning their operations with the latest research and technology integrations, enhancing product efficacy. ECO Animal Health Group PLC, Elanco Animal Health Incorporated, and Heska Corporation further enrich this diverse landscape by pioneering sustainable and cost-effective solutions.

Not to be overlooked, Hester Biosciences Limited, Indian Immunologicals Ltd., and Intas Pharmaceuticals Ltd. leverage deep local insights and scientific acumen to serve niche market segments. The involvement of Laboratorio Drag Pharma Chile Invetec S.A. alongside global leaders like Merck & Co., Inc. emphasizes the growing importance of multinational collaborations in this industry. Neogen Corporation, Norbrook Group, Phibro Animal Health Corporation, and Teknofarma S.r.l. provide additional layers of expertise, shaping both product development and market strategy through consistent innovation and research-driven methodologies.

Other prominent players including Vetoquinol Group, Vetpharma Animal Health S.L. by Insud Pharma S.L.U., Virbac S.A., Zendal Group, and Zoetis Inc. serve as key contributors to the market's evolving landscape. Their ongoing investments in research and cross-continental partnerships are central to driving industry progress and addressing emerging challenges. The wide-ranging expertise, from biotechnological advancements to comprehensive distribution networks, encapsulates the multi-dimensional approach that these companies bring to critical market segments.

The report delves into recent significant developments in the Veterinary Pharmaceuticals Market, highlighting leading vendors and their innovative profiles. These include Aurora Pharmaceutical, Inc., Biogenesis Bago S.A., Biovac Ltd., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Chanelle Pharma, China Animal Husbandry Industry Co., Ltd., Dechra Pharmaceuticals PLC, ECO Animal Health Group PLC, Elanco Animal Health Incorporated, Heska Corporation, Hester Biosciences Limited, Indian Immunologicals Ltd., Intas Pharmaceuticals Ltd., Laboratorio Drag Pharma Chile Invetec S.A., Merck & Co., Inc., Neogen Corporation, Norbrook Group, Phibro Animal Health Corporation, Teknofarma S.r.l., Vetoquinol Group, Vetpharma Animal Health S.L. by Insud Pharma S.L.U., Virbac S.A., Zendal Group, and Zoetis Inc.. Actionable Recommendations for Strategic Industry Advancement

In an industry marked by rapid transformative change, industry leaders must align their strategic objectives with innovative practices and forward-thinking policies. The actionable recommendations outlined here are intended to propel growth, enhance operational efficiencies, and secure a competitive advantage in the veterinary pharmaceuticals market.

First, prioritizing research and development is critical. Embracing emerging technologies such as artificial intelligence and precision medicine can enable companies to create more targeted and effective therapeutic solutions. Collaborative efforts with academic institutions and research centers can further catalyze innovation, ensuring that product pipelines reflect both current needs and future trends. Leveraging digital transformation to enhance data analytics and clinical trial management is a powerful catalyst for achieving breakthrough treatments.

Furthermore, diversifying product portfolios represents an indispensable strategy. By expanding into various subsegments-ranging from drugs and medicinal feed to vaccines-companies can mitigate risk while tapping into niche markets. Strategic investments in the development of advanced formulations, such as biotechnologically enhanced vaccines and targeted anti-inflectives, would not only broaden market reach but also improve overall treatment efficacies. Understanding the complex segmentation based on animal type, mode of administration, and specific disease indications will allow for the development of purpose-driven solutions that cater to a broad spectrum of needs.

A second recommendation centers on optimizing distribution channels. In a market where channel efficiency directly influences accessibility and sales performance, companies are advised to bolster partnerships with both traditional outlets and emerging digital platforms. Enhancements in online pharmacies, retail partnerships, and veterinary clinic networks can streamline product availability and improve customer engagement. Mapping out supply chain efficiencies and integrating robust logistics systems will prove beneficial in reducing lead times and enhancing service quality.

Third, fostering strategic alliances remains a potent avenue for sustained growth. Forming robust alliances with local and international partners can facilitate knowledge transfer, expedite market entry, and offer avenues for joint research initiatives. For instance, aligning with regional distributors and local players in high-growth markets, such as those found in the Asia-Pacific and Europe, Middle East & Africa, can offer unique market insights and accelerate penetration strategies.

Lastly, maintaining an agile mindset in the face of regulatory and market changes is non-negotiable. In a landscape heavily shaped by evolving standards and consumer expectations, organizations must commit to continually updating their operational protocols and compliance measures. This dynamic approach can safeguard against emerging risks and ensure that companies remain ahead of regulatory shifts. By continuously monitoring market trends and integrating adaptive strategies, industry leaders can navigate uncertainties while capitalizing on new opportunities.

The above recommendations are designed to guide strategic decision-making, ensuring that companies do not merely react to industry changes but actively shape the future of veterinary pharmaceuticals. A balanced focus on research, technological innovation, product diversification, channel optimization, and strategic partnerships will pave the way for sustained market leadership.

Conclusion: Navigating the Future with Informed Strategies

In summary, the evolving landscape of the veterinary pharmaceuticals market is characterized by an interplay of innovation, rigorous research, and adaptive business strategies. This comprehensive analysis has underscored the significance of in-depth segmentation, revealing the nuanced differences in product categories, animal types, modes of administration, indications, distribution channels, and end users. These segmentation insights empower decision-makers with the groundwork needed to tailor strategies that can effectively navigate both macro and micro level market trends.

Furthermore, regional insights have highlighted that distinct geographies such as the Americas, Europe, Middle East & Africa, and Asia-Pacific each offer unique opportunities and challenges. Whether driving innovation in technologically advanced regions or tapping into the growth potential of developing markets, organizations must adopt a flexible and localized strategy. The global perspective reinforces that strategic agility and regional specificity are crucial to maintaining competitiveness in a dynamic environment.

The competitive analysis provided a snapshot of key industry players, illustrating the diverse approaches they employ to remain at the forefront of innovation. From multinational conglomerates to emerging local enterprises, the collective efforts in research and development, product diversification, and strategic alliances are reshaping market dynamics. This convergence of expertise and market presence demonstrates that sustained success is a result of both rigorous planning and adaptive practices.

As we look to the future, the veterinary pharmaceuticals market is poised to benefit from continuous technological advancements and a deeper understanding of consumer needs. The integration of cutting-edge research with market-driven strategies is leading the way towards a new era of innovation in animal healthcare. Ultimately, the road ahead is defined by informed decision-making, strategic foresight, and a relentless commitment to excellence in every facet of business operations.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidence of diseases in livestock and companion animals, rising need for treatment and medications
      • 5.1.1.2. Increase in R&D activities for veterinary healthcare
    • 5.1.2. Restraints
      • 5.1.2.1. Risk of recalls associated with veterinary drugs and vaccines
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of new and advanced veterinary pharmaceuticals
      • 5.1.3.2. Increasing investment by companies for the expansion of veterinary vaccine facilities
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with the adverse effects of veterinary vaccine
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Products: The growing demand for medicinal feed to improve animal health and productivity
    • 5.2.2. Animal Type: Growing need for veterinary pharmaceuticals in livestock animals owing to disease control and productivity enhancement
    • 5.2.3. Mode of Administration: Increasing utilization of capsules for ensuring dosage accuracy
    • 5.2.4. Indications: Emerging focus on the introduction of drugs advancing treatments for metabolic disorders
    • 5.2.5. Distribution Channel: Growing consumer preference for online pharmacies owing to their convenience and wide range of products
    • 5.2.6. End User: Expanding applications of veterinary pharmaceuticals by pet owners
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Veterinary Pharmaceuticals Market, by Products

  • 6.1. Introduction
  • 6.2. Drugs
    • 6.2.1. Analgesics
    • 6.2.2. Anti-Infectives
      • 6.2.2.1. Antibiotics
      • 6.2.2.2. Antifungals
    • 6.2.3. Anti-Inflammatories
      • 6.2.3.1. Non-Steroidal
      • 6.2.3.2. Steroidal
    • 6.2.4. Parasiticides
      • 6.2.4.1. Ectoparasiticides
      • 6.2.4.2. Endoparasiticides
  • 6.3. Medicinal Feed
    • 6.3.1. Antibiotic Medicated Feed
    • 6.3.2. Antiparasitic Medicated Feed
    • 6.3.3. Growth Promoters
    • 6.3.4. Nutritional Medicated Feed
    • 6.3.5. Probiotic & Prebiotic Medicated Feed
  • 6.4. Vaccines
    • 6.4.1. Inactivated Vaccines
    • 6.4.2. Live Vaccines

7. Veterinary Pharmaceuticals Market, by Animal Type

  • 7.1. Introduction
  • 7.2. Companion Animals
    • 7.2.1. Cats
    • 7.2.2. Dogs
    • 7.2.3. Horses
  • 7.3. Livestock Animals
    • 7.3.1. Cattle
    • 7.3.2. Poultry
    • 7.3.3. Sheep & Goats
    • 7.3.4. Swine

8. Veterinary Pharmaceuticals Market, by Mode of Administration

  • 8.1. Introduction
  • 8.2. Injectable
    • 8.2.1. Intramuscular
    • 8.2.2. Subcutaneous
  • 8.3. Oral
    • 8.3.1. Capsules
    • 8.3.2. Liquid Suspension & Syrup
    • 8.3.3. Tablets
  • 8.4. Topical
    • 8.4.1. Creams
    • 8.4.2. Lotions
    • 8.4.3. Ointments

9. Veterinary Pharmaceuticals Market, by Indications

  • 9.1. Introduction
  • 9.2. Chronic & Acute Pain Management
  • 9.3. Immunological Conditions
  • 9.4. Infectious Diseases
  • 9.5. Metabolic Disorders
  • 9.6. Neurological Disorders
  • 9.7. Orthopedic Disorders
  • 9.8. Parasitic Infections
  • 9.9. Reproductive Health

10. Veterinary Pharmaceuticals Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Online Pharmacies
  • 10.3. Retail Pharmacies
  • 10.4. Veterinary Clinics

11. Veterinary Pharmaceuticals Market, by End User

  • 11.1. Introduction
  • 11.2. Animal Farms
  • 11.3. Pet Owners
  • 11.4. Veterinary Hospitals

12. Americas Veterinary Pharmaceuticals Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Veterinary Pharmaceuticals Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Veterinary Pharmaceuticals Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. Dechra Pharmaceuticals to acquire Invetx to enhance veterinary therapeutics portfolio
    • 15.3.2. TechInvention and Botswana Institute partner to revolutionize veterinary vaccine production
    • 15.3.3. Merck Animal Health introduces innovative RNA-particle Canine Flu vaccine
    • 15.3.4. Huvepharma Expands with EUR 72 million veterinary vaccine plant to boost global supply and innovation
    • 15.3.5. Virbac strengthens position in Japanese market with Sasaeah acquisition
    • 15.3.6. FDA approvals enhance veterinary treatments for heart and respiratory conditions
    • 15.3.7. Impact of EVML on global veterinary medicine accessibility and AMR mitigation
    • 15.3.8. Zendal and CSIC unveil innovative Neoleish vaccine to combat canine leishmaniasis
    • 15.3.9. Merck Animal Health acquires Elanco's aqua business to strengthen aquaculture presence
    • 15.3.10. Huateng Pharma expands with fluralaner and sarolaner launch, revolutionizing veterinary pharmaceuticals
    • 15.3.11. ENTOD Pharmaceuticals expands into veterinary market with "FUR by ENTOD" division
    • 15.3.12. Indian Immunologicals Ltd (IIL) invests INR 700 crore in Hyderabad vaccine plant to boost livestock disease eradication
    • 15.3.13. Virbac acquires stake in Globion to boost avian vaccine market presence in India
    • 15.3.14. Strategic collaboration between Pirbright Institute and USask's VIDO to boost vaccine innovation and pandemic readiness
  • 15.4. Strategy Analysis & Recommendation
    • 15.4.1. Dechra Pharmaceuticals PLC
    • 15.4.2. Zoetis Inc.
    • 15.4.3. Ceva Sante Animale
    • 15.4.4. Boehringer Ingelheim GmbH

Companies Mentioned

  • 1. Aurora Pharmaceutical, Inc.
  • 2. Biogenesis Bago S.A.
  • 3. Biovac Ltd.
  • 4. Boehringer Ingelheim International GmbH
  • 5. Ceva Sante Animale
  • 6. Chanelle Pharma
  • 7. China Animal Husbandry Industry Co., Ltd.
  • 8. Dechra Pharmaceuticals PLC
  • 9. ECO Animal Health Group PLC
  • 10. Elanco Animal Health Incorporated
  • 11. Heska Corporation
  • 12. Hester Biosciences Limited
  • 13. Indian Immunologicals Ltd.
  • 14. Intas Pharmaceuticals Ltd.
  • 15. Laboratorio Drag Pharma Chile Invetec S.A.
  • 16. Merck & Co., Inc.
  • 17. Neogen Corporation
  • 18. Norbrook Group
  • 19. Phibro Animal Health Corporation
  • 20. Teknofarma S.r.l.
  • 21. Vetoquinol Group
  • 22. Vetpharma Animal Health S.L. by Insud Pharma S.L.U.
  • 23. Virbac S.A.
  • 24. Zendal Group
  • 25. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. VETERINARY PHARMACEUTICALS MARKET MULTI-CURRENCY
  • FIGURE 2. VETERINARY PHARMACEUTICALS MARKET MULTI-LANGUAGE
  • FIGURE 3. VETERINARY PHARMACEUTICALS MARKET RESEARCH PROCESS
  • FIGURE 4. VETERINARY PHARMACEUTICALS MARKET SIZE, 2023 VS 2030
  • FIGURE 5. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 19. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 23. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 27. EUROPE, MIDDLE EAST & AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 28. VETERINARY PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 29. VETERINARY PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VETERINARY PHARMACEUTICALS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VETERINARY PHARMACEUTICALS MARKET DYNAMICS
  • TABLE 7. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY NON-STEROIDAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY STEROIDAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ECTOPARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ENDOPARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTIC MEDICATED FEED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTIPARASITIC MEDICATED FEED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY GROWTH PROMOTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY NUTRITIONAL MEDICATED FEED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PROBIOTIC & PREBIOTIC MEDICATED FEED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVE VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY CATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DOGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY HORSES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY SHEEP & GOATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY SWINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIQUID SUSPENSION & SYRUP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY CREAMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 58. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY LOTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 59. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 60. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 61. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 62. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY CHRONIC & ACUTE PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 63. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY IMMUNOLOGICAL CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 64. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 65. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 66. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 67. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORTHOPEDIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 68. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITIC INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 69. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY REPRODUCTIVE HEALTH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 70. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 72. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 73. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 74. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL FARMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 76. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PET OWNERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 77. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 78. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 79. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 80. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
  • TABLE 81. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
  • TABLE 82. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
  • TABLE 83. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
  • TABLE 84. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 85. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 87. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 88. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 89. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 90. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 91. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 92. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 93. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. AMERICAS VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 96. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 97. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 98. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
  • TABLE 99. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
  • TABLE 100. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
  • TABLE 101. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
  • TABLE 102. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 103. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 105. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 106. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 107. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 108. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 109. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 110. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 111. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. ARGENTINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 114. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 115. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
  • TABLE 116. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
  • TABLE 117. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
  • TABLE 118. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
  • TABLE 119. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 120. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 122. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 123. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 124. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 125. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 126. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 127. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 128. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 129. BRAZIL VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 131. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 132. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
  • TABLE 133. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
  • TABLE 134. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
  • TABLE 135. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
  • TABLE 136. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 137. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 139. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 140. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 141. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 142. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 143. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 144. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 145. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. CANADA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 148. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 149. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
  • TABLE 150. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
  • TABLE 151. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
  • TABLE 152. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
  • TABLE 153. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 154. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 156. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 157. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 158. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 159. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 160. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 161. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 162. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 163. MEXICO VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 165. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 166. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
  • TABLE 167. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
  • TABLE 168. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
  • TABLE 169. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
  • TABLE 170. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 171. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 173. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 174. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 175. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 176. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 177. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 178. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 179. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 200. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 201. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 202. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
  • TABLE 203. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
  • TABLE 204. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
  • TABLE 205. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
  • TABLE 206. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 207. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 209. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 210. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 211. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 212. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 213. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 214. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 215. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 216. AUSTRALIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 217. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 218. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 219. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
  • TABLE 220. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
  • TABLE 221. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
  • TABLE 222. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
  • TABLE 223. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 224. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 226. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 227. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 228. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 229. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 230. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 231. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 232. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 233. CHINA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 234. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 235. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 236. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
  • TABLE 237. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
  • TABLE 238. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
  • TABLE 239. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
  • TABLE 240. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 241. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 243. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 244. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 245. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 246. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 247. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 248. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 249. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 250. INDIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 251. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 252. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 253. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
  • TABLE 254. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
  • TABLE 255. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
  • TABLE 256. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
  • TABLE 257. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 258. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 260. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 261. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 262. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 263. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 264. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 265. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 266. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 267. INDONESIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 268. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 269. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 270. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
  • TABLE 271. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
  • TABLE 272. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
  • TABLE 273. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
  • TABLE 274. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 275. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 277. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 278. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 279. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 280. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 281. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 282. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 283. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 284. JAPAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 285. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 286. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 287. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
  • TABLE 288. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
  • TABLE 289. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
  • TABLE 290. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
  • TABLE 291. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 292. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 293. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 294. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 295. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 296. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 297. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 298. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 299. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 300. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 301. MALAYSIA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 302. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 303. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 304. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2030 (USD MILLION)
  • TABLE 305. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2030 (USD MILLION)
  • TABLE 306. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2018-2030 (USD MILLION)
  • TABLE 307. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY MEDICINAL FEED, 2018-2030 (USD MILLION)
  • TABLE 308. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 309. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 310. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 311. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
  • TABLE 312. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 313. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
  • TABLE 314. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
  • TABLE 315. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 316. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 317. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 318. PHILIPPINES VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 319. SINGAPORE VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 320. SINGAPORE VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 321. SINGAPORE VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANT